# Climb Bio, Inc. (CLYM)

> Source: Nexqual · https://nexqual.com/CLYM · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Climb Bio, Inc. (CLYM), nexqual.com/CLYM" · informational, not investment advice.

**Price:** USD 10.91 (+6.03% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 10.29 · day 10.25–10.98 · 52w 1.64–18.33 · market cap $627M · NGM

## Key facts
- Analysts: Buy (mean 1.87 on a 1–5 scale) (15 analysts), mean target USD 27.57 (range 18–40).
- Total return with dividends: 1Y +459.5% vs S&P 500 +18.1%; 5Y -32.4% vs S&P 500 +85.1%.
- Next earnings: 2026-11-13, EPS estimate USD -0.19, revenue estimate $0K.

## Analysts
Consensus Buy (mean 1.87 on a 1–5 scale), 15 analysts; mean target USD 27.57 (low 18, high 40).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-08 | Oppenheimer | Target raised | Outperform | $18 → $25 |
| 2026-09-08 | HC Wainwright & Co. | Target raised | Buy | $24 → $30 |
| 2026-09-04 | B. Riley Securities | Target raised | Buy | $26 → $30 |
| 2026-09-03 | BTIG | Target raised | Buy | $20 → $32 |
| 2026-09-03 | Baird | Target raised | Outperform | $21 → $25 |
| 2026-08-24 | HC Wainwright & Co. | Target raised | Buy | $20 → $24 |
| 2026-08-19 | Wedbush | Reiterated | Outperform | $20 |
| 2026-08-07 | Truist Securities | Target raised | Buy | $17 → $25 |
| 2026-07-27 | Wedbush | Target raised | Outperform | $17 → $20 |
| 2026-06-24 | HC Wainwright & Co. | Reiterated | Buy | $20 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | +459.5% | -32.4% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +462.8% | -7.5% |
| Volatility (annualized) | 92.0% | 101.2% |
| Max drawdown | -42.3% (Aug 2026→Oct 2026) | -93.7% (Oct 2021→Mar 2025) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/CLYM · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt